CLINICAL_TRIALS
trial_result
· 2025-11-20
Clinical Trial Update: High Dose Carfilzomib for Newly Diagnosed Myeloma [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating high-dose carfilzomib in newly diagnosed multiple myeloma has completed enrollment with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-20